Apr 24, 2020 - Glaxo's (GSK) Vaccines and Respiratory segments are likely to have driven sales in the first quarter. Results will provide clarity on the impact of coronavirus on the company's business.
Apr 27, 2020 - Let us take a look at three big drug companies due to release their first-quarter financial results on Apr 28.
Apr 27, 2020 - Top Research Reports for Intel, Novartis & Toyota
Sep 08, 2020 - Novartis (NVS) posts favorable data on asthma treatment Enerzair Breezhaler at the ERS International Congress 2020.
Sep 14, 2020 - Novartis (NVS) announces positive data on Beovu from an ongoing late-stage study for the DME indication.
Sep 15, 2020 - Novartis' (NVS) eye drug Beovu's safety label update receives approval from the Committee for Medicinal Products for Human Use.
Sep 18, 2020 - Here at Zacks, our focus is on the proven Zacks Rank system, which emphasizes earnings estimates and estimate revisions to find great stocks. Nevertheless, we are always paying attention to the latest value, growth, and momentum trends to underscore strong picks.
Sep 29, 2020 - AbbVie's (ABBV) elezanumab is presently being evaluated in a phase II study for spinal cord injury.